Skip Navigation
MUSC mobile menu
  • Fast-Track: Sickle Cell Drug Targets Key Enzyme

    Woster research an awardee in Sickle Cell Disease/Advancing Cures funding; fast-track research focused on developing a new gene-modifying sickle cell disease treatment at MUSC could lead to human clinical trials in as few as three years.

  • Nappi and Haney Honored at MUSC Convocation

    Jean Nappi (MUSC Foundation Distinguished Faculty Service Award) and Jason Haney (MUSC Teaching Excellence Award in Educator-Mentor:Clinical/Professional) were recognized for excellence during the 2017 MUSC Faculty Convocation.
  • drug discovery

    The College

    The College of Pharmacy at the Medical University of South Carolina provides a premier pharmacy education leveraging the innovative inter-professional learning opportunities offered at South Carolina’s only comprehensive academic health center with a full range of programs in the biomedical sciences.

  • Welcome Home Weekend

    Registration for MUSC College of Pharmacy Welcome Home Weekend is now live! Festivities include the Vincent T. Peng Endowed Lectureship (CE), lunch with the dean, a day-in-the-life panel with current students and the traditional Lowcountry Oyster Roast. Visit the Welcome Home website for information.


  • Mikell Named MUSC Pharmacy Honorary Alumnus of the Year

    The 2017 White Coat Ceremony featured as keynote speaker Nancy G. Mikell, who was also presented with the Honorary Alumnus of the Year Award. Mikell's address was the highlight of a week of 2017 Orientation activities capped by the ceremony at Baruch Auditorium August 17.   

  • Clinical Pharmacy and Outcomes Science

    Faculty nationally recognized for achievement in both teaching and practice provide interprofessional education and training in patient care, critical thinking and professional leadership.

Doris Levkoff Meddin Center for Medication Safety Education Program

meddinWhile drugs reduce morbidity and mortality, and cure or provide palliative treatments for diseases, drugs also produce adverse effects.  These adverse effects can be minor or can cause serious complications, delay recovery, increase hospital stays and cause death.  Further, as the number of medications an individual takes increases the risk of adverse effects increases.  This not only includes the number of prescription drugs but also includes the consumption of non-prescription drugs and supplements (e.g. herbal).  Finally, an additional dimension to the problem of medication safety is patients at risk, children and the elderly.  Children and the elderly are known to respond to drugs differently than the general population, and, as such, are at a greater risk of adverse effects.  In addition, many of the potential adverse effects are not known because most drugs are not routinely tested in children and the elderly.  Thus, insufficient scientific and clinical data impede our ability to identify, treat, and prevent adverse effects, particularly in children and the elderly.
The vision for the Doris Levkoff Meddin Center for Medication Safety Education Program to be the leader in identifying and determining the incidence of adverse drug effects, elucidating the mechanisms of adverse drug effects, and educating health care professionals and the public in recognizing and preventing adverse drug effects, particularly in children and the elderly.
Fighting sickle cell disease by looking to babyhood
Oct 12, 2017 6:32:00 PM EDT

Fast-track research focused on developing a new gene-modifying sickle cell disease treatment at the Medical University of South Carolina could lead to human clinical trials in as few as three years....Read more...

View MUSC's Facebook page Follow MUSC on Twitter View the MUSC Health Youtube channel Read the MUSC Health blog circle arrow MUSC_TAG_SOLID_1C